Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
Tumor testing cost-effective for triage to germline testing in HGSOC patients
HONOLULU – Tumor testing for the triage of women with high-grade serous ovarian cancer to confirmatory genetic...
News
ENGOT-OV16/NOVA trial: Analysis shows improved TWiST with niraparib
An analysis of ENGOT-OV16/NOVA trial data showed improved time without toxicity and symptoms (TWiST) in patients with recurrent ovarian cancer...
News
MRD status at transplant predicts outcomes in ALL patients
HOUSTON – Acute lymphoblastic leukemia patients with measurable residual disease (MRD) negativity prior to...
News
Secondary AML in first remission predicts outcomes
HOUSTON – Secondary AML predicts outcomes after SCT in first complete remission, whereas factors such as age, cytogenetics, and performance status...
News
Haplo-HSCT bests chemotherapy for MRD-positive adult ALL
HOUSTON – Haplo-HSCT outperforms chemotherapy for the treatment of adults with ALL in first complete response, particularly MRD-positive patients...
News
Therapeutic dosing of busulfan helps reduce relapse in ASCT
HOUSTON - Pharmacokinetic-directed therapeutic dose monitoring of busulfan used in combination with cyclophosphamide and etoposide appears to...
News
Novel transplant regimen improves survival in primary immunodeficiency
HOUSTON – Allo-HCT following a novel reduced-intensity conditioning regimen was largely successful in an NIH study of adults and children with...
News
Survey: CRC diagnosis often delayed or initially missed in patients under age 50
Over half of young CRC patients responding to a survey had at least three symptoms and still waited at least 3 months before visiting a doctor.
News
SEER data: Abiraterone acetate may up mortality risk in prostate cancer patients with CVD
A review of SEER-Medicare linked data suggests an increased mortality risk with abiraterone acetate treatment in prostate cancer patients with vs...
News
Diet appears to play an important role in response to anti-PD-1 cancer immunotherapy
Diet appears to affect response to anti-PD-1 cancer immunotherapy, likely by its effect on the gut microbiome.
News
Myositis mimics: Clues for making the right diagnosis
A number of conditions can mimic myositis, but clues that can point to the correct diagnosis are often present in cases involving the mimics.
News
Barriers to CAR T use in the spotlight at first European meeting
European approvals of CAR T-cell therapy are prompting a closer look at economic issues, outcomes data, and future directions.
News
NILE: Liquid biopsy bests tissue testing for targetable mutations in NSCLC
Liquid biopsy was more effective and faster than tissue-based genotyping for identifying targetable mutations in advanced NSCLC in the prospective...
News
Midostaurin maintenance may reduce relapse risk in FLT3-ITD+ AML
HOUSTON – The effect was most pronounced in those with high pFLT3 inhibition on plasma inhibitor activity assay.